Online citations, reference lists, and bibliographies.
← Back to Search

Spasmodic Laryngeal Dyspnea: A Rare Manifestation Of Laryngeal Dystonia

P. Zwirner, D. Dressler, E. Kruse
Published 2004 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
We describe clinical experiences in the management of three patients with laryngopharyngeal dystonia causing severe breathing problems. In contrast to spasmodic dysphonia, which presents with action-induced involuntary spasms of laryngeal muscles during speaking, all three patients showed laryngopharyngeal spasms primarily during respiration. In analogy to spasmodic dysphonia we propose the term spasmodic laryngeal dyspnea for this rare condition. Localized unilateral botulinum toxin injected into the thyroarytenoid muscle and /or ventricular folds reduced the quantity and quality of spasms and led to a pronounced improvement of breathing problems.
This paper references
10.1016/0140-6736(92)91060-L
Stridor and focal laryngeal dystonia
M. H. Marion (1992)
10.1001/ARCHOTOL.1987.01860060029009
Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report.
R. Miller (1987)
[Dystonia as the cause of pharyngolaryngeal motility disorders].
P. Zwirner (1995)
10.1177/000348949110000201
Laryngeal Dystonia: A Series with Botulinum Toxin Therapy
A. Blitzer (1991)
Spastic dysphonia . I . Changing interpretation of a persistent affliction
GE Arnold (1959)
10.1002/MDS.870020402
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm
M. Brin (1987)
Systonie als Ursache pharyngolaryngealer Motilitätsstörungen
P. Zwirner (1995)
Clinical Voice Disorders: An Interdisciplinary Approach
A. Aronson (1980)
10.1288/00005537-198802000-00015
Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia)
A. Blitzer (1988)
Indication de la toxine botulique en laryngologie.
P. Klap (1993)
10.1016/S0892-1997(05)80168-7
Use of flexible fiberoptic laryngoscopy to assess patients with spasmodic dysphonia
G. Woodson (1991)
10.1002/MDS.870090307
Adductor laryngeal breathing dystonia in a patient with lubag (X‐linked dystonia‐parkinsonism syndrome)
M. Lew (1994)
10.1002/MDS.870080220
Postneuroleptic laryngeal dyskinesias: A cause of upper airway obstructive syndrome improved by local injections of botulinum toxin
A. Fève (1993)
10.1288/00005537-199401000-00007
Treatment of adductor laryngeal breathing dystonia with botulinum toxin type a
Gregory A. Grillone (1994)
Use of fiberoptic laryngoscopy to assess patients with spasmodic dysphonia
GE Woodson (1991)
10.1288/00005537-198806000-00012
Clinical and laboratory characteristics of focal laryngeal dystonia: Study of 110 cases
Andrew Blitzer, Dds (1988)



This paper is referenced by
10.1002/lary.28559
Respiratory Laryngeal Dystonia: Characterization and Diagnosis of a Rare Neurogenic Disorder.
William G. Tierney (2020)
10.1002/mds.25219
DYT7 gene locus for cervical dystonia on chromosome 18p is questionable
P. Winter (2012)
10.1111/j.1533-2500.2004.04012.x
Treatment of Neck and Shoulder Pain with Botulinum Neurotoxins
A. Herskowitz (2004)
10.1055/S-0043-115644
Die Behandlung der laryngealen Dystonie mit Botulinumtoxin
Arno Olthoff (2017)
10.1212/WNL.78.1_MEETINGABSTRACTS.P01.223
Dystonic Respiratory Dysregulation and Other Breathing Disorders Associated with Dystonia (P01.223)
Raja Mehanna (2012)
10.1016/B978-1-4160-4928-9.00010-X
Chapter 10 – Botulinum Neurotoxin in Tremors, Tics, Hemifacial Spasm, Spasmodic Dysphonia, and Stuttering
A. Bentivoglio (2009)
10.1111/j.1469-8749.2006.02015a.x
Sudden death in Lesch‐Nyhan disease
Vladimir Kostadinov Neychev (2006)
10.1016/S0967-5868(03)00020-1
Spasmodic dysphonia: clinical features and effects of botulinum toxin therapy in 169 patients—an Australian experience
S. Tisch (2003)
10.1212/WNL.0000000000001206
Adductor laryngeal exhaling dystonia in progressive supranuclear palsy
K. Kawamura (2015)
10.1007/978-3-7091-1516-9_10
Botulinum Toxin Therapy of Dystonia
D. Dressler (2015)
10.1097/MLG.0b013e31814684fa
Overall Evaluation of Effectiveness of Type II Thyroplasty for Adductor Spasmodic Dysphonia
T. Sanuki (2007)
10.1007/978-1-4614-4466-4_16
Spastic Facial Muscle Disorders
Juwan Park (2012)
10.1002/mds.25865
The clinical spectrum of laryngeal dystonia includes dystonic cough: Observations of a large series
S. Payne (2014)
10.1007/978-1-4614-4466-4
Craniofacial Muscles
L. McLoon (2013)
10.1016/j.mib.2012.05.012
Clinical applications of botulinum toxin.
D. Dressler (2012)
10.1111/j.1468-1331.2006.01443.x
Botulinum toxin therapy of laryngeal muscle hyperactivity syndromes: comparing different botulinum toxin preparations
D. Truong (2006)
10.1002/mds.25269
Respiratory disorders associated with dystonia
R. Mehanna (2012)
10.1002/mds.20020
Basic immunological aspects of botulinum toxin therapy
M. Atassi (2004)
10.1007/s00405-006-0165-0
Idiopathic laryngeal spasm: management and long-term outcome
D. Pinder (2006)
10.1007/s00405-016-4289-6
Botulinum toxin injection in laryngeal dyspnea
V. Woisard (2016)
10.1002/mds.25567
The focal dystonias: Current views and challenges for future research
H. Jinnah (2013)
10.1016/S0022-510X(02)00046-1
Different mechanism of vocal cord paralysis between spinocerebellar ataxia (SCA 1 and SCA 3) and multiple system atrophy
E. Isozaki (2002)
10.1017/S0012162206002015
Sudden death in Lesch-Nyhan disease.
Vladimir K. Neychev (2006)
10.1111/j.1468-1331.2010.03058.x
Botulinum toxin for treatment of dystonia
D. Dressler (2010)
10.1007/s00106-011-2477-7
Zur oromandibulären, pharyngealen und laryngealen Anwendung von Botulinumtoxin
Arno Olthoff (2011)
10.1212/01.wnl.0000252893.90894.0b
Primary craniocervical dystonia presenting as a respiratory emergency
S. Papapetropoulos (2007)
10.1002/lary.23708
Sleep‐related adductor Laryngeal dystonia causing sleep apnea
R. Marchese-Ragona (2013)
Semantic Scholar Logo Some data provided by SemanticScholar